Cargando…

How can we design better vaccines to prevent HIV infection in women?

The human immunodeficiency virus (HIV) burden in women continues to increase, and heterosexual contact is now the most common route of infection worldwide. Effective protection of women against HIV-1 infection may require a vaccine specifically targeting mucosal immune responses in the female genita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rafferty, Hannah, Sibeko, Sengeziwe, Rowland-Jones, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219488/ https://www.ncbi.nlm.nih.gov/pubmed/25408686 http://dx.doi.org/10.3389/fmicb.2014.00572

Ejemplares similares

How Can We Better Prevent Obesity in Children?
por: Visscher, Tommy L. S., et al.
Publicado: (2015)

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
por: Matthews, Lynn T., et al.
Publicado: (2013)

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Implementing guidelines to prevent cancer associated thrombosis: how can we do better?
por: Ades, Steven, et al.
Publicado: (2023)

Terminal Care: How Can We Do Better?
por: Wilkes, Erik
Publicado: (1986)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
por: Park, Hyun-Eui, et al.
Publicado: (2021)

COVID-19 VACCINATION AMONGST INFERTILITY STAFF: HOW CAN WE DO BETTER?
por: Bergin, Keri, et al.
Publicado: (2021)

Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
por: Van Regenmortel, Marc H. V.
Publicado: (2018)

Mimicking Antigen-Driven Asthma in Rodent Models—How Close Can We Get?
por: Alessandrini, Francesca, et al.
Publicado: (2020)

Can We Prevent Antimicrobial Resistance by Using Antimicrobials Better?
por: Soothill, Germander, et al.
Publicado: (2013)

Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?
por: Fink, Katja
Publicado: (2019)

Lipids in cell biology: how can we understand them better?
por: Muro, Eleonora, et al.
Publicado: (2014)

Robot-assisted laparoscopic prostatectomy: How can we get better?
por: Omorphos, Nicolas, et al.
Publicado: (2020)

Eradicating Infectious Disease: Can We and Should We?
por: Russell, Clark Donald
Publicado: (2011)

Challenges in HIV Vaccine Research for Treatment and Prevention
por: Ensoli, Barbara, et al.
Publicado: (2014)

HIV RNA Suppression and Immune Restoration: Can We Do Better?
por: Pinzone, Marilia Rita, et al.
Publicado: (2012)

Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools
por: De Groot, Anne S., et al.
Publicado: (2020)

How Can We Prevent False Hydrophobia?
por: Spitzka, E. C.
Publicado: (1886)

How Mandatory Can We Make Vaccination?
por: Saunders, Ben
Publicado: (2022)

Biomaterials for Pelvic Floor Reconstructive Surgery: How Can We Do Better?
por: Gigliobianco, Giulia, et al.
Publicado: (2015)

Online lectures in undergraduate medical education: how can we do better?
por: Tang, Brandon, et al.
Publicado: (2019)

Increasing adverse drug reaction reporting—How can we do better?
por: Potlog Shchory, Miri, et al.
Publicado: (2020)

How can we better frame COVID-19 public health messages?
por: Teye-Kwadjo, Enoch
Publicado: (2022)

Balancing service and education for the medical trainee: how can we do better?
por: Rajendran, L
Publicado: (2022)

Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?
por: Horvath, Augusta, et al.
Publicado: (2023)

Aerosol Therapy in Asthma–Why We Are Failing Our Patients and How We Can Do Better
por: Morton, Robert W., et al.
Publicado: (2020)

Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?
por: Krammer, Florian
Publicado: (2020)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
por: da Silva, Laís Teodoro, et al.
Publicado: (2018)

Osteoarthritis: Can We Do Better?
por: Collins, Dylon P, et al.
Publicado: (2022)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the “Pink Swan”
por: Cardona, Pere-Joan
Publicado: (2017)

Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design
por: Subramaniam, Krishanthi S., et al.
Publicado: (2020)

Design Challenges for HIV-1 Vaccines Based on Humoral Immunity
por: Greenspan, Neil S.
Publicado: (2014)

CD4 binding determinant mimicry for HIV vaccine design
por: Nishiyama, Yasuhiro, et al.
Publicado: (2012)

How we can prevent a resurgence this year
por: Lee, Jong-Koo
Publicado: (2023)

Addressing threats like Covid: why we will tend to over-react and how we can do better
por: Pingle, Mark
Publicado: (2022)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

How Should We Classify Kawasaki Disease?
por: Marrani, Edoardo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_onmfvqvi6jr1g4hmveb5kbvjq0